Advanced search
Start date
Betweenand

The role of lipid metabolism and ACLY in neuroinflammation.

Grant number: 25/00985-4
Support Opportunities:Regular Research Grants
Start date: August 01, 2025
End date: July 31, 2027
Field of knowledge:Biological Sciences - Immunology - Cellular Immunology
Mobility Program: SPRINT - Projetos de pesquisa - Mobilidade
Principal Investigator:Pedro Manoel Mendes de Moraes Vieira
Grantee:Pedro Manoel Mendes de Moraes Vieira
Principal researcher abroad: Juliana M Navia Pelaez
Institution abroad: Saint Louis University (SLU), United States
Host Institution: Instituto de Biologia (IB). Universidade Estadual de Campinas (UNICAMP). Campinas , SP, Brazil
Associated research grant:20/16030-0 - Immunometabolic adaptation of tissue resident macrophages in health and disease, AP.TEM

Abstract

Microglia and neuroinflammation in the spinal cord are major contributors to central sensitization and chronic pain development but their phenotype dynamics and molecular contributions during pain are poorly understood. Defining the mechanisms by which microglial lipid metabolism affects immune responses and neuronal sensitization will improve our understanding and help to better identify and develop novel targets and therapeutic interventions for safer pain treatments. The overall goal of this project is to unveil the role of ACLY and cholesterol in microglial phenotypic switch and reprogramming during persistent pain states. We aim to validate ACLY as a non-opioid target for pain treatment. A multi-disciplinary team of basic science investigators from UNICAMP (Brazil) and Saint Louis University (USA) will intersect cutting-edge tools, novel rodent and cell-based assays, and high-dimensional omics analysis to advance our understanding of how immunometabolism regulate pain processes in mice. (AU)

Articles published in Agência FAPESP Newsletter about the research grant:
More itemsLess items
Articles published in other media outlets ( ):
More itemsLess items
VEICULO: TITULO (DATA)
VEICULO: TITULO (DATA)